+691.4%
MRNA vs MDLN
+13.6%
+677.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MDLN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -1.5% | -5.1% | -6.1% |
| 7D | +8.4% | +24.2% | -15.9% | +2.2% |
| 30D | +28.8% | +11.8% | +17.0% | +24.6% |
| 3M | +329.2% | +8.4% | +320.8% | +315.5% |
| 6M | +416.9% | -12.3% | +429.2% | +399.0% |
| YTD | +718.8% | -5.3% | +724.1% | +690.8% |
| All | +691.4% | +13.6% | +677.8% | +662.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MDLN.
Daily Out/Under-Performance
Portfolio return minus MDLN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MDLN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MDLN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling